help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 26, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0208
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/9/3383    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pouratian, N.
Right arrow Articles by Laws, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pouratian, N.
Right arrow Articles by Laws, E. R., Jr
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Neuroendocrinology and Pituitary
Right arrow Endocrine Oncology

Submitted on January 29, 2007
Accepted on June 15, 2007

Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery

Nader Pouratian*, Daniel M. Prevedello, Jay Jagannathan, M. Beatriz Lopes, Mary Lee Vance, and Edward R. Laws Jr

Department of Neurological Surgery, Department of Pathology, Division of Neuropathology, Department of Medicine, Division of Endocrinology; University of Virginia, Charlottesville, Virginia

* To whom correspondence should be addressed. E-mail: np5k{at}virginia.edu.

Context: Despite the success of transsphenoidal surgery (TSS) for the treatment of Cushing's disease, in a number of cases, an ACTH-staining pituitary adenoma is not identified histologically. The clinical significance of lack of histological confirmation remains unclear.

Setting: Retrospective review of patients treated at the University of Virginia Medical Center.

Patients: Out of 490 TSS procedures for Cushing's disease between 1993 and 2004, we identified 111 cases without histological adenoma confirmation.

Main Outcome Measure: Remission and recurrence of Cushing's disease.

Results: Overall, 50% of these patients achieved remission, a figure lower than for our entire series (79%) and for patients with histological confirmation of an ACTH-staining adenoma (88%)(p<0.001). Patients with a history of 2 prior TSS achieved remission less often than patients with a history of fewer TSS (p=0.026). No other factors influenced remission rates. Although the overall recurrence rate (21%, 7 of 33 evaluated) was not different from previously published long term studies, in 3 of 7 cases of recurrence, early recurrences were noted between 2 and 4 months after remission. In patients who did not achieve remission, the most common and effective treatment options were repeat TSS, Gamma Knife radiosurgery, and bilateral adrenalectomy.

Conclusion: The lower remission rate in patients without histological evidence of an adenoma is most likely a result of a decreased rate of adenoma extirpation. The incidence of early recurrence may be a unique feature of this patient population; patients without histological confirmation of tumor resection therefore require close and consistent monitoring postoperatively.


Key words: Cushing's disease • outcomes assessment • pituitary adenoma




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Carrasco, J. Coste, L. Guignat, L. Groussin, M. A. Dugue, S. Gaillard, X. Bertagna, and J. Bertherat
Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing's Disease
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4728 - 4734.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. G. Patil, D. M. Prevedello, S. P. Lad, M. L. Vance, M. O. Thorner, L. Katznelson, and E. R. Laws Jr.
Late Recurrences of Cushing's Disease after Initial Successful Transsphenoidal Surgery
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 358 - 362.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society